General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Novartis Institutes for BioMedical Research (NIBR)

The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization of Novartis. With approximately 6 000 scientists and physicians around the world, our research is focused on discovering innovative new drugs that will change the practice of medicine. We have an open and entrepreneurial culture, encouraging collaboration to make effective therapies.

At NIBR, you will have the opportunity to work alongside an extraordinarily talented and diverse group of people from around the globe, all committed to making a difference for our patients and customers.

“Drug discovery is today’s frontier of science. The interface of the chemical, biological and medical universes is a difficult place to work, worthy of the best minds and most innovative scientists.”

Mark Fishman, President of NIBR

We have opportunities globally in the following research areas:

  • Cardiovascular and Metabolic Diseases
  • Oncology
  • Infectious Diseases
  • Musculoskeletal Diseases
  • Ophthalmology
  • Analytical and Imaging Sciences
  • Biologics
  • Global Discovery Chemistry
  • Developmental & Molecular Pathways
  • Center for Proteomic Chemistry
  • Epigenetics
  • Translational Medicine
  • Preclinical Safety
  • DMPK and Biomarker Development

Novartis encourages submission of CVs/resumes in response to open positions.